Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C20H19F2N5O2.2ClH.H2O |
| Molecular Weight | 889.725 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.OC(=O)[C@H]1C2CCC(CC2)[C@@H]1NC3=C(F)C=NC(=N3)C4=CNC5=C4C=C(F)C=N5.OC(=O)[C@H]6C7CCC(CC7)[C@@H]6NC8=C(F)C=NC(=N8)C9=CNC%10=C9C=C(F)C=N%10
InChI
InChIKey=WPLSKBKDOCXXMO-KIHJVYKPSA-N
InChI=1S/2C20H19F2N5O2.2ClH.H2O/c2*21-11-5-12-13(7-24-17(12)23-6-11)18-25-8-14(22)19(27-18)26-16-10-3-1-9(2-4-10)15(16)20(28)29;;;/h2*5-10,15-16H,1-4H2,(H,23,24)(H,28,29)(H,25,26,27);2*1H;1H2/t2*9?,10?,15-,16-;;;/m00.../s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H19F2N5O2 |
| Molecular Weight | 399.394 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P03427 Gene ID: NA Gene Symbol: PB2 Target Organism: Influenza A virus (strain A/Wilson-Smith/1933 H1N1) (Influenza A virus|||(strain A/WS/1933 H1N1)) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27451344 |
|||
Target ID: CHEMBL612610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25019388 |
0.32 nM [EC50] | ||
Target ID: CHEMBL262 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25019388 |
1.6 µM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial. | 2019-03-15 |
|
| Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy volunteers. | 2018-11 |
|
| Pimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study. | 2018 |
|
| Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza. | 2017-02-09 |
|
| JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses. | 2016-09 |
|
| Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. | 2014-08-14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:47:04 GMT 2025
by
admin
on
Mon Mar 31 18:47:04 GMT 2025
|
| Record UNII |
A256039515
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000013057
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
A256039515
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
121488178
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
C174596
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
EF-36
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
1777721-70-6
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
PRIMARY | |||
|
1777814-24-0
Created by
admin on Mon Mar 31 18:47:04 GMT 2025 , Edited by admin on Mon Mar 31 18:47:04 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
ANHYDROUS->SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |